Envista Holdings (NVST) Amortization of Deferred Charges (2020 - 2026)
Envista Holdings (NVST) posted quarterly Amortization of Deferred Charges of $9.1 million for Q2 2026, up 727.27% year-over-year from $1.1 million in Q2 2025, and down 71.11% quarter-over-quarter from $31.5 million in Q4 2025.
Envista Holdings (NVST) Amortization of Deferred Charges (2020 - 2026) Analysis & Trends
Envista Holdings' Amortization of Deferred Charges history runs 7 years deep, the most recent figure standing at $9.1 million for Q2 2026.
- In Q2 2026, Amortization of Deferred Charges rose 727.27% year-over-year to $9.1 million; the TTM figure through Apr 2026 stood at $42.0 million (up 357.67% YoY), while the FY2025 annual figure was $34.7 million, up 608.16% from the prior year.
- Amortization of Deferred Charges for Q2 2026 stood at $9.1 million, down from $31.5 million in the prior quarter.
- The five-year high for Amortization of Deferred Charges was $31.5 million in Q4 2025, with the low at -$18.2 million in Q4 2024.
- The 5-year median for Amortization of Deferred Charges is $800000.0 (2022), against an average of $3.9 million.
- The sharpest annual moves came in 2024 and 2026: Amortization of Deferred Charges slumped 1616.67% in 2024, then soared 727.27% in 2026.
- Envista Holdings' Amortization of Deferred Charges stood at $21.3 million in 2022, then tumbled by 94.37% to $1.2 million in 2023, then plunged by 1616.67% to -$18.2 million in 2024, then surged by 273.08% to $31.5 million in 2025, then sank by 71.11% to $9.1 million in 2026.
- Business Quant data shows NVST's Amortization of Deferred Charges at $9.1 million in Q2 2026, $31.5 million in Q4 2025, and $700000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn |
| 10 | Envista Holdings | 4.40 Bn | 3.27 Bn | 407.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 3, 2026 | 700,000.00 |
| Jul 3, 2026 | 700,000.00 |
| Apr 3, 2026 | 9.10 Mn |
| Apr 3, 2026 | 9.10 Mn |
| Dec 31, 2025 | 31.50 Mn |
| Dec 31, 2025 | 31.50 Mn |
| Sep 26, 2025 | 700,000.00 |
| Sep 26, 2025 | 700,000.00 |
| Jun 27, 2025 | 700,000.00 |
| Jun 27, 2025 | 700,000.00 |
| Mar 28, 2025 | 1.10 Mn |
| Mar 28, 2025 | 1.10 Mn |
| Dec 31, 2024 | -18.20 Mn |
| Dec 31, 2024 | -18.20 Mn |
| Sep 27, 2024 | 100,000.00 |
| Sep 27, 2024 | 100,000.00 |
| Jun 28, 2024 | 700,000.00 |
| Jun 28, 2024 | 700,000.00 |
| Mar 29, 2024 | 7.30 Mn |
| Mar 29, 2024 | 7.30 Mn |